Serina Therapeutics Announces Advancing to Multi-Dose Phase in Parkinson’s Disease Patients in the SER-214 Phase I Trial By 100 Danish|2016-06-06T15:42:55+00:00June 6th, 2016|Uncategorized|0 Comments Share This Story, Choose Your Platform! About the Author: 100 Danish Related Posts Serina Therapeutics Announces Publication of Invited Feature Article in European Polymer Journal Serina Therapeutics Announces Publication of Invited Feature Article in European Polymer Journal Serina Therapeutics Announces President and CEO will Deliver Invited Lecture on POZ Therapeutics at Annual American Chemical Society Meeting in Philadelphia Serina Therapeutics Announces President and CEO will Deliver Invited Lecture on POZ Therapeutics at Annual American Chemical Society Meeting in Philadelphia